- Kopetz, S., Yoshino, T., Van Cutsem, E., Eng, C., Kim, T., Wasan, H., …Tabernero, J. (2025). Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial. Nature medicine, 31(3). https://doi.org/10.1038/s41591-024-03443-3
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
on 5 de maig de 2025
with No hi ha comentaris
Deixa un comentari